News and Trends 18 Nov 2022
Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC
…the only approved treatment for CAD and is a first-in-class humanized monoclonal antibody that is designed to selectively target and inhibit the classical complement pathway specific serine protease, C1s. It…